Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Liver Neoplasms

• HAIC Combined Sintilimab for Liver Metastasis From Esophageal Squamous Cell Carcinoma
• Ciprofol Sedation in Patients Undergoing Liver Cancer Percutaneous Radiofrequency Ablation
• Postoperative Analgesia With Liposomal Bupivacaine Versus Standard Bupivacaine Combined With Dexamethasone
• Postoperative Chemotherapy With/Without Radiotherapy and Immunotherapy for Colorectal Liver Metastases With High Risk of Locally Recurrence
• Tislelizumab Plus TKI as Adjuvant Therapy Versus Active Surveillance in Patients With HCC
• Dexmedetomidine-esketamine for Percutaneous Radiofrequency Liver Ablation
• Fluorescence-guided Resection Of Colorectal Liver Metastases Using SGM-101 and Indocyanine GREEN
• Goal-directed vs Preemptive Tranexamic Acid Administration in Non-cardiac Surgery
• Serplulimab+Regorafenib +Hepatic Artery Bicarbonate Infusion in Patients With Colorectal Cancer and Liver Metastases
• Cryoablation Combined With Tislelizumab Plus Lenvatinib In Previously Treated Gastric Cancer Liver Metastasis (CASTLE-09)
• The Safety and Efficacy of HAIC+Tislelizumab+Regorafenib in Patients With Colorectal Liver Metastases
• Multimodal Model for Efficacy Prediction Cetuximab in Colorectal Cancer Liver Metastasis Patient
• COLLISION RELAPSE Trial
• SIR-Spheres Study to Calculate the Radiation-Absorbed Dose of 99mTc-MAA
• Hepatic Arterial Infusion Chemotherapy in Combination With Atezolizumab and Bevacizumab for Second-line Treatment of Patients With Recurrent Liver Cancer After Liver Transplantation
• ctDNA-guided Adjuvant Chemotherapy in Liver Metastasis of Colorectal Cancer
• Postoperation Maintenance Therapy for Resectable Liver Metastases of Colorectal Cancer Guided by ctDNA
• Regorafenib Combined With Irinotecan Drug-Eluting Beads for Colorectal Cancer Liver Metastases
• AU409 for the Treatment of Advanced Primary Liver Cancers or Solid Tumor With Liver Metastatic Disease
• A Phase 1 Dose-escalation and Expansion Study of the PD-1 x ILT4 Bispecific Antibody CDX-585 in Patients With Advanced Malignancies
• Quintuple Method for Treatment of Multiple Refractory Colorectal Liver Metastases
• Applicability of PDOX in Patients With Primary Liver Cancer: A Randomized Controlled Trial
• Clinical Study of mRNA Vaccine in Patients With Liver Cancer After Operation
• Domvanalimab and Zimberelimab in Advanced Liver Cancers
• Study on Screening, Verification and Intervention of High-risk Patients With Liver Cancer
• Early Blocking Strategy for Metachronous Liver Metastasis of Colorectal Cancer Based on Pre-hepatic CTC Detection
• SIRT With Tremelimumab and Durvalumab for Resectable HCC
• Applicability of 3D-HDRA in Patients With Primary Liver Cancer: A Randomized Controlled Trial
• Fecal Microbiota Transfer in Liver Cancer to Overcome Resistance to Atezolizumab/Bevacizumab (FLORA)
• Recombinant Human Adenovirus Type 5 Injection Combined With PD-1 Monoclonal Antibody and Nab-paclitaxel in the Treatment of Patients With Liver Metastases From Malignant Melanoma
• Camrelizumab Combined With Bevacizumab and HAIC in Patients With Metastatic Liver Cancer Who Failed Standard Therapy
• Safety and Efficacy of Bifidobacterium Therapy in Patients With Advanced Liver Cancer Receiving Immunotherapy
• Study of Bevacizumab in Combination With Chemoimmunotherapy and Atezolizumab in Patients With Extensive Stage Small Cell Lung Cancer and Liver Metastases
• Preoperative Nivolumab Plus Bevacizumab Combined With Chemotherapy Before Surgery in Patients With pMMR/MSS Colorectal Cancer Liver Metastases
• TACE Combined With Camrelizumab and Apatinib in the Treatment of Advanced Liver Cancer
• Sintilimab Combined With Regorafenib and HAIC in Patients With Colorectal Liver Metastasis
• A Phase 1/2 Study to Evaluate OTX-2002 in Patients With Hepatocellular Carcinoma and Other Solid Tumor Types Known for Association With the MYC Oncogene
• Clinical Recruitment of Patients With First-line Targeted Drug Resistance or Intolerance to Hepatocellular Cancer With PD-1 Inhibitor (Toripalimab,JS001) Detected on the NGS Platform Combined With Anlotinib
• Durvalumab and Tremelimumab in Combination With Propranolol and Chemotherapy for Treatment of Advanced Hepatopancreabiliary Tumors (BLOCKED)
• Oral Axl/Mer/CSF1R Selective Tyrosine Kinase Inhibitor Q702 in Combination With Pembrolizumab in Patients With Selected Advanced Solid Tumors
• mFOLFOX7 Plus Camrelizumab and Apatinib for Advanced HCC
• Exploratory Study on Combined Conversion Immunotherapy for Liver Metastasis of MSS Type Initial Unresectable Colorectal Cancer Based on Gene Status
• Cryoablation Combined With Tislelizumab Plus Lenvatinib in Patients With Melanoma Liver Metastasis
• Hepatic Arterial Infusion Chemotherapy With Fruquintinib for Colorectal Cancer Liver Metastases As Third-line Therapy
• A Pilot Study to Assess the Clinical Utility of PYLARIFY PET-CT for Detecting Metastasis in Pancreatic Cancer, Hepatocellular Carcinoma and Breast Cancer
• Fluorescent-labeled IgG for Liver Tumor Detection
• A Study of exoASO-STAT6 (CDK-004) in Patients With Advanced Hepatocellular Carcinoma (HCC) and Patients With Liver Metastases From Primary Gastric Cancer and Colorectal Cancer (CRC)
• To Explore the Safety and Efficacy of Intravenous Infusion of Different Doses of Lidocaine in Patients
• Study of Tislelizumab in Combination With SOX for the Treatment of Gastric Cancer With Liver Metastases
• A Study of MRG002 in the Treatment of Patients With HER2-positive Breast Cancer With Liver Metastases.
• TACE Combined With Lenvatinib Versus TACE Sequential Lenvatinib in the Treatment of Intermediate/Advanced Liver Cancer
• A Study to Determine Whether Chemotherapy, Bevazicumab, and Atezolizumab is Better Than Chemotherapy Alone in Patients With Advanced Liver Cancer
• Atezolizumab and Bevacizumab Pre-Liver Transplantation for Patients With Hepatocellular Carcinoma Beyond Milan Criteria
• Composition for Treating Cirrhosis and Liver Cancer (SB-1121)
• Radiofrequency Ablation Combined With Toripalimab and Lenvatinib in the Treatment of Short-term Recurrent Hepatocellular Carcinoma.
• Indocyanine Green Molecular Fluorescence Imaging Technique Using in Diagnosis and Treatment of Primary Liver Cancer
• Trial of PXS-5505 Combined With First Line Atezolizumab Plus Bevacizumab For Treating Patients With Unresectable Hepatocellular Carcinoma
• Interleukin-15 Armored Glypican 3-specific Chimeric Antigen Receptor Expressed in Autologous T Cells for Hepatocellular Carcinoma
• Cryoablation Combined With Sintilimab Plus Lenvatinib In Previously Treated Unresectable Liver Metastasis From Solid Tumors
• Low-dose Neuroleptanalgesia for Postoperative Delirium in Elderly Patients
• ctDNA-Directed Post-Hepatectomy Chemotherapy for Patients With Resectable Colorectal Liver Metastases
• Cryoablation Combined With Sintilimab Plus Regorafenib In Previously Treated Colorectal Cancer Liver Metastasis
• Lenvatinib Plus Sintilimab in Patients With Immune Checkpoint Inhibitor Previously Treated Advanced Liver Cancer
• GPC3 Targeted CAR-T Cell Therapy in Advanced GPC3 Expressing Hepatocellular Carcinoma (HCC)
• ALPPS Combined With Tislelizumab in Liver Malignancy
• Hepatic Artery Infusion Chemotherapy Plus Donafenib in Patients With Hepatocellular Carcinoma After Surgery
• Neoantigen Dendritic Cell Vaccine and Nivolumab in HCC and Liver Metastases From CRC
• Preoperative Irinotecan Drug-eluting Beads for Patients With Unresectable Colorectal Liver Metastasis
• A Study to Assess the Safety, Tolerability, and Pharmacokinetics of ABSK-011 in Patients With Advanced Solid Tumor
• A Trial of Camrelizumab Combined With Microwave Ablation and Chemotherapy in the Treatment of Colorectal Cancer Liver Metastasis/Pulmonary Metastasis
• T-Cell Therapy (ECT204) in Adults With Advanced HCC
• EXtended CriteriA Treatment for LIver Metastases and Heavy Tumour BURden
• Intra-arterial Hepatic (IAH) Infusion of Radiolabelled Somatostatin Analogs in GEP-NET Patients With Dominant Liver Metastases
• The Effect of Ultrasound-guided Erector Spinae Plane Block on Postoperative Analgesia in Radiofrequency Ablation Therapy
• FOLFOXIRI Plus Cetuximab Versus FOLFOXIRI Plus Bevacizumab in Conversion Therapy of Right-sided Colon Cancer Liver Metastases
• Clinical Study of VG161 in Subjects With Advanced Primary Liver Cancer
• Electromagnetic Fields Versus Placebo as Third-line Therapy For Patients With Advanced Hepatocellular Carcinoma
• Hepatic Hilar Nerve Block Versus Sham in Pain Control During Liver Ablation and TACE Procedures
• Anesthesia on Gut Microbiota and Metabolomics
• Conversion Therapy of RAS/BRAF Wild-Type Colorectal Cancer Patients With Initially Unresectable Liver Metastases
• Safety, Tolerability, PK, Anti-Tumor Activity of STP705 Injected IT in Cholangiocarcinoma, Hepatocellular Carcinoma or Liver Metastases in Subjects With Advanced/Metastatic or Surgically Unresectable Solid Tumors Who Are Refractory to Standard Thera
• ET140203 T Cells in Pediatric Subjects With Hepatoblastoma, HCN-NOS, or Hepatocellular Carcinoma
• HAIC Combined With Bevacizumab and Toripalimab for Advanced Hepatocellular Carcinama
• HAIC Combined With Lenvatinib and Sintilimab for Hepatocellular Carcinoma With PVTT
• An Exploratory Study of Atezolizumab and Bevacizumab in Hepatocellular Carcinoma and Non-Small Cell Lung Cancer With Liver Metastases (INTEGRATE)
• Microwave Ablation Combined With Chemotherapy for Colorectal Liver Metastases： a Multicenter Cohort Study
• Conversion Therapy of RAS/BRAF Wild-Type Right-sided Colon Cancer Patients With Initially Unresectable Liver Metastases
• A Study Evaluating the Efficacy and Safety of Multiple Immunotherapy-Based Treatment Combinations in Patients With Advanced Liver Cancers (Morpheus-Liver)
• Study on the Effectiveness and Safety of Carrelizumab Combined With Apatinib Mesylate and Radiotherapy in the Treatment of Advanced Liver Cancer
• Cetuximab Re-challenge for Colorectal Cancer Liver Metastasis
• A Study of the PD-L1xCD27 Bispecific Antibody CDX-527 in Patients With Advanced Malignancies
• A Trial of Camrelizumab Combined With Ablation and Chemotherapy in Patients With Pancreatic Cancer Liver Metastasis（SHR-1210-HLJ-009）
• A Study of Nivolumab and Ipilimumab and Nivolumab Alone in Combination With Trans-arterial ChemoEmbolization (TACE) in Participants With Intermediate Stage Liver Cancer
• Efficacy of Intravenous Lidocaine on Postoperative Pain and Recovery in Patients Undergoing Hepatectomy
• mFOLFIRINOX Followed by Hepatic Arterial Infusion of Floxuridine and Dexamethasone With Systemic mFOLFIRI for Unresectable Liver-dominant Intrahepatic Cholangiocarcinoma
• MGD013 Monotherapy and Combination With Brivanib Dose Escalation and Expansion Study in Advanced Liver Cancer Patients
• The Safety and Efficacy of Thermal Ablation Combined With Apatinib and Carilimub for Advanced Liver Cancer
• Phase II Study of Neoadjuvant Immune Checkpoint Inhibitor in Patients With Resectable Gastrointestinal Cancers
• Combined Immunotherapy and Targeted Therapy for Advanced Liver Cancer
• Checkpoint Inhibition In Pediatric Hepatocellular Carcinoma
• Immunotherapy With Y90-RadioEmbolization for Metastatic Colorectal Cancer
• T Cells co- Expressing a Second Generation Glypican 3-specific Chimeric Antigen Receptor With Cytokines Interleukin-21 and 15 as Immunotherapy for Patients With Liver Cancer (TEGAR)
• BreCLIM-2 - A RCT Investigating Local Treatment for Breast Cancer Liver Metastases
• Sorafenib Plus Toripalimab for Unresectable HCC With Portal Vein Tumor Thrombus
• Local Immunomodulation After Radiofrequency of Unresectable Colorectal Liver Metastases
• High Dose Vitamin C Combined With Metformin in the Treatment of Malignant Tumors
• Axitinib Plus Toripalimab as Second-line Treatment in Hepatobiliary Malignant Tumors
• A Study of E7386 in Combination With Other Anticancer Drug in Participants With Solid Tumor
• Treatment With Hepatic Arterial Infusion of Oxaliplatin in Combination With Systemic FOLFIRI Chemotherapy and Bevacuzimab in Patients With Liver-only Colorectal Liver Metastases (CRLM): Conversion to Complete Resection in Patients With Initially Ino
• A Randomized Phase II Trial of Surgery Plus Sorafenib vs. Sorafenib Alone for Hepatocellular Cancer (HCC) With Portal Vein Invasion
• Infusion of PD1/PDL1 Inhibitor Via Hepatic Arterial Versus Vein for Immunotherapy of Advanced Hepatocellular Carcinoma
• Lenvatinib Combined Pembrolizumab in Advanced Hepatobiliary Tumors
• Hepatic Artery Infusional Floxuridine to Treat Pancreatic Cancer Liver Metastases
• Pembrolizumab After Chemotherapy in Treating Patients With Colorectal Cancer That Has Spread to the Liver and Who Are Undergoing Liver Surgery
• Clinical Trial of Cinobufacini Combined With Transarterial Chemoembolization (TACE) on Primary Liver Cancer
• Improving Outcome of Selected Patients With Non-resectable Hepatic Metastases From Colo-rectal Cancer With Liver Transplantation
• A Study to Evaluate MIV-818 in Patients With Liver Cancer Manifestations
• Anlotinib in the Treatment of Advanced Hepatocellular Carcinoma (HCC)
• Spinal Anesthesia For Enhanced Recovery After Liver Surgery
• PF-06952229 Treatment in Adult Patients With Advanced Solid Tumors
• TSR-022 (Anti-TIM-3 Antibody) and TSR-042 (Anti-PD-1 Antibody) in Patients With Liver Cancer
• A Study of the Efficacy of Cannabidiol in Patients With Multiple Myeloma, Glioblastoma Multiforme, and GI Malignancies
• Study of A166 in Patients With Relapsed/Refractory Cancers Expressing HER2 Antigen or Having Amplified HER2 Gene
• Intra-arterial Lutetium-177-dotatate for Treatment of Patients With Neuro-endocrine Tumor Liver Metastases
• Transarterial Chemoembolization in Combination With Nivolumab Performed for Intermediate Stage Hepatocellular Carcinoma
• Cisplatin and Combination Chemotherapy in Treating Children and Young Adults With Hepatoblastoma or Liver Cancer After Surgery
• Combined Immunotherapy and Radiosurgery for Metastatic Colorectal Cancer
• Systemic Chemotherapy Plus HAI(FUDR）vs Systemic Chemotherapy Alone For CRCLM
• A Study of RC48-ADC Administered Intravenously to Patients With HER2-Positive Metastatic Breast Cancer With or Without Liver Metastases
• A Study of Systemic Chemotherapy With CPT-11 Plus HAI (FUDR+L-OHP) in Patients With Initially Unresectable CRCLM
• Cetuximab Plus FOLFOXIRI vs Cetuximab Plus FOLFOX For CRCLM
• Targeted Delivery of Chemotherapy With Ultrasound and Microbublles
• TCR-engineered T Cells in Solid Tumors: IMA202-101
• EPA for Metastasis Trial 2
• Effect of Terlipressinum on the Portal Vein Pressure of Patients With Liver Tumor After Liver Resection
• A Study of CDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced Malignancies
• Aspirin in Colorectal Cancer Liver Metastases
• Study of GNS561 in Patients With Liver Cancer
• Combination of TATE and PD-1 Inhibitor in Liver Cancer
• Bioinformation Therapy for Liver Cancer
• Improving CBCT for Liver IG-SBRT Using Gadoxetate Disodium
• Combination Chemotherapy and Bevacizumab With the NovoTTF-100L(P) System in Treating Participants With Advanced, Recurrent, or Refractory Hepatic Metastatic Cancer
• Clinical Trial of Metastasis Inhibitor NP-G2-044 in Patients With Advanced or Metastatic Treatment-Refractory Solid Tumor Malignancies
• Oral STAT3 Inhibitor, TTI-101, in Patients With Advanced Cancers
• Celebrex and Metformin for Postoperative Hepatocellular Carcinoma
• Effect of SAMe Treatment on Recurrence After Radical Treatment of Primary Hepatic Carcinoma
• Irinotecan-Eluting Bead (DEBIRI) for Patients With Liver Metastases From Colorectal Cancer
• Clinical Trial of Elemene in Combination With Oxaliplatinin the Treatment of Advanced Primary Liver Cancer
• Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil/Leucovorin Versus Sorafenib in Advanced Hepatocellular Carcinoma
• To Evaluate the Efficacy of NY-ESO-1-specific T Cell Receptor Affinity Enhancing Specific T Cell in Solid Tumors
• Effect of Pregabalin on the Postoperative Analgesia in RFA of Focal Lesions in the Liver
• A Study to Test the Safety and Feasibility of Nivolumab With Drug Eluting Bead Transarterial Chemoembolization in Patients With Liver Cancer
• Consolidative Radiotherapy for Colorectal Cancer Liver Metastases Receiving Surgery or Radiofrequency Ablation
• Study Comparing Radio Frequency Ablation Plus Chemotherapy and Chemotherapy Alone in Patients With Unresectable CRLM
• Synergism of Immunomodulation and Tumor Ablation
• A Study of SHR-1210 in Combination With Apatinib or Chemotherapy in Subjects With Advanced PLC or BTC
• Parecoxib Versus Celecoxib Versus Oxycodone in Pain Control for Transcatheter Chemoembolization Procedure
• A Phase 1/2 Safety Study of Intratumorally Dosed INT230-6
• APL-501 Study for Select Advanced or Relapsed/Recurrent Solid Tumors
• Sorafenib Induced Autophagy Using Hydroxychloroquine in Hepatocellular Cancer
• An Evaluation of Tilmanocept by IV Injection Using SPECT/CT vs PET Imaging in Subjects With Liver Metastases.
• Sorafenib and Bavituximab Plus SBRT in Unresectable Hepatocellular Carcinoma
• Clinical Trial Comparing TACE With TACE + SABR in Stage BCLC B HCC (HepSTAR)
• Phase I/Ib Study of NIS793 in Combination With PDR001 in Patients With Advanced Malignancies.
• Pembrolizumab With or Without Elbasvir/Grazoprevir and Ribavirin in Treating Patients With Advanced Refractory Liver Cancer
• Glypican 3-specific Chimeric Antigen Receptor Expressed in T Cells for Patients With Pediatric Solid Tumors (GAP)
• APAP-CYS Protein Adduct Concentrations in Patients With Liver-Directed Therapy Intended to Treat Hepatic Tumors
• Sulfur Colloid SPECT/CT in Measuring Liver Function in Patients With Primary or Metastatic Liver Cancer Undergoing Radiation Therapy or Surgery
• Study of TBI-1301 (NY-ESO-1 Specific TCR Gene Transduced Autologous T Lymphocytes) in Patients With Solid Tumors
• Cabozantinib-S-Malate in Treating Younger Patients With Recurrent, Refractory, or Newly Diagnosed Sarcomas, Wilms Tumor, or Other Rare Tumors
• Precision Cell Immunotherapy Combined With TACE in Advanced Liver Cancer
• Effect of Surefire Infusion Device on Tumor Response to Regional Intra-arterial Therapy for Primary Liver Malignancies
• Phase 1 Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of H3B-6527 in Participants With Advanced Hepatocellular Carcinoma
• Effects of Antiviral Therapy on HBV Reactivation
• A Pilot Study of Combined Immune Checkpoint Inhibition in Combination With Ablative Therapies in Subjects With Hepatocellular Carcinoma (HCC) or Biliary Tract Carcinomas (BTC)
• TACE vs TACE+SBRT for Unresectable Hepatocellular Cancer
• Tremelimumab (Anti-CTLA-4) Plus MEDI4736 (Anti-PD-L1) in Resectable Colorectal Cancer Liver Metastases
• Pharmacokinetics of Doxorubicin in cTACE of Liver Cancer
• Phase I , MTD, Pharmacokinetic, Safety/Tolerability, Efficacy of IOP Injection for MRI in Healthy Subjects
• Ultrasound Monitoring of Abdominal Soft Tissue
• First-in-Human Safety, Tolerability and Antitumour Activity Study of MTL-CEBPA in Patients With Advanced Liver Cancer
• Treatment Patients With Pulmonary Metastasis of Liver Cancer With Apatinib Combination With TACE: a Clinical Study
• An Open Study Assessing the Safety and Tolerability of U3-1784
• T Cell Mediated Adaptive Therapy for Her2-positive Neoplasms of Digestive System
• Study of Metatinib Tromethamine Tablet
• Effect of Smoked Plum and Chewing Gum on Postoperative Bowel Function Following Hepatic Resection
• Spinal Versus Epidural Analgesia in Laparotomic Liver Surgery
• Phase I Trial of Radiation Therapy in Patients With Liver Cancers and Impaired Liver Function
• HCC Patient Preferences in Japan
• Tas-102 and Radioembolization With 90Y Resin Microspheres for Chemo-refractory Colorectal Liver Metastases
• MRI With Gadoxetate Disodium in Measuring Tumors in Patients With Liver Cancer
• MLN0128 Compared to Sorafenib in Advanced or Metastatic Hepatocellular Carcinoma
• Hepatic Arterial Infusion of Oxaliplatin and Fluorouracil Treatment of Advanced Primary Liver Cancer After TACE
• Oxaliplatin and Raltitrexed Treatment of Colorectal Cancer With Liver Metastases
• A Phase I Study of Lyso-thermosensitive Liposomal Doxorubicin and MR-HIFU for Pediatric Refractory Solid Tumors
• Alternating Systemic and Hepatic Artery Infusion Therapy As Adjuvant Treatment After Resection of Liver Metastases From Colorectal Cancer
• Effects of OXY111A in Primary and Secondary Hepato-Pancreato-Biliary Neoplasm
• Analgesia by Transversus Abdominis Plane Nerve Block in Patients Undergoing Liver Resection.
• Trial to Evaluate the Safety of Talimogene Laherparepvec Injected Into Tumors Alone and in Combination With Systemic Pembrolizumab MK-3475-611/Keynote-611
• Integrated Imaging Strategy to Phenotype Progression of Liver Tumors During and After Chemoembolization
• Metabolic Radiotherapy After Complete Resection of Liver Metastases in Patient With Digestive Neuroendocrine Tumor
• Compare Efficacy and Safety of Raltitrexed-based and 5fu-based Neoadjuvant Chemotherapy for Colorectal Liver Metastasis
• Survivorship Promotion In Reducing IGF-1 Trial
• Feasibility 3D Perfusion Ultrasound for Liver Cancer SABR Planning and Response Evaluation
• Ropidoxuridine in Treating Patients With Advanced Gastrointestinal Cancer Undergoing Radiation Therapy
• Perioperative Chemotherapy With Herceptin For Potentially Resectable HER-2 Positive Gastric Cancer With Liver Metastasis
• Colectomy in Patients With Asymptomatic and Unresectable Stage IV Colon Cancer
• Treatment of Liver Metastases With Electrochemotherapy (ECTJ) Phase II
• Omega-3 Fatty Acid-Based Parenteral Nutrition Improves Postoperative Recovery for Cirrhotic Patients With Liver Cancer
• Phase I:Decitabine by Hepatic Arterial Infusion(HAI) in Unresectable Liver Metastases Colorectal Cancer (CRC)
• Trametinib in Combination With Sorafenib in Patients With Advanced Hepatocellular Cancer
• Treatment of Primary Liver Tumors With Electrochemotherapy (ECT)
• Sorafenib Concurrent With Yttrium-90 Transarterial Radioembolization in Patients With Advanced Hepatocellular Cancer
• Ultrasound Guided Thoracic Paravertebral Block for Hepatic Tumors Ablation
• Resveratrol and Human Hepatocyte Function in Cancer
• Ipilimumab and Stereotactic Body Radiation Therapy (SBRT) in Advanced Solid Tumors
• Physiologic Assessment Following Gadoxetic Acid and Gadobenate Dimeglumine Administration
• Preliminary Results for the Double-dose Adenovirus-mediated Adjuvant Therapy Improving Outcome of Liver Transplantation in Patients With Advanced Hepatocellular Carcinoma
• Safety, Pharmacokinetics and Preliminary Anti-Tumor Activity of Intravenous TKM-080301 in Subjects With Advanced Hepatocellular Carcinoma
• Safety and Pharmacokinetics of SM04755 in Subjects With Advanced Colorectal, Gastric, Hepatic, or Pancreatic Cancer
• Chemoembolisation of Hepatocellular Carcinomas Not Subject to Interventive Care by Idarubicin-loaded Beads - IDASPHERE II
• Targeted Chemotherapy Using Focused Ultrasound for Liver Tumours
• Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
• Vitamin D in Patients With Stage I-III Colon Cancer or Resectable Colon Cancer Liver Metastases
• Contrast-enhanced MRI in Detecting Benign and Malignant Liver Lesions
• A Pharmacodynamic Study of Sirolimus and Metformin in Patients With Advanced Solid Tumors
• NAC to Prevent Cisplatin-induced Hearing Loss
• PERIOPERATIVE TREATMENT WITH COI-B (CAPECITABINE, OXALIPLATIN, IRINOTECAN AND BEVACIZUMAB) OF HIGH RISK OR BORDERLINE RESECTABLE COLORECTAL CANCER LIVER METASTASES
• A Study of Emibetuzumab in Combination With Ramucirumab (LY3009806) in Participants With Advanced Cancer
• Sorafenib Tosylate in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery
• Radiolabeled Glass Beads in Treating Patients With Liver Cancer That Cannot be Removed by Surgery
• Trametinib in Treating Patients With Advanced Cancer With or Without Hepatic Dysfunction
• Dose Escalation Study of OMP-54F28 in Combination With Sorafenib in Patients With Hepatocellular Cancer
• 3-Tesla MRI Response to TACE in HCC (Liver Cancer)
• Effects of Dexmedetomidine During IRE Procedures for Solid Tumours
• Trametinib or Combination Chemotherapy in Treating Patients With Refractory or Advanced Biliary or Gallbladder Cancer or That Cannot Be Removed by Surgery
• A Randomized Double-blind, Placebo-controlled Japanese Phase III Trial of ARQ 197 in Hepatocellular Carcinoma (HCC)
• Effects of Dexmedetomidine During Radiofrequency Ablation of Abdominal Tumours
• Phase II Study of Neoadjuvant XELOX + Lapatinib in HER2(+) Gastric Cancer Patients With Liver Metastasis
• A Study of Avastin (Bevacizumab) and Xeloda (Capecitabine) in Patients With Advanced or Metastatic Liver Cancer
• Imetelstat Sodium in Treating Younger Patients With Relapsed or Refractory Solid Tumors
• Intraoperative Intraportal Chemotherapy Combined With Adjuvant Chemotherapy for Stage II and III Colorectal Cancer
• T Cell Receptor Immunotherapy Targeting NY-ESO-1 for Patients With NY-ESO-1 Expressing Cancer
• Preoperative Chemotherapy With Bevacizumab For Potentially Resectable Gastric Cancer With Liver Metastasis
• Clinical Study of Antiviral and Aspirin Treatment in Liver Cancer After Radical Surgery
• Sorafenib in Liver Function Impaired Advanced Hepatocellular Carcinoma
• Sorafenib Tosylate and Yttrium Y 90 Glass Microspheres in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery
• Acupoint Electric Stimulation Combined With Tropisetron in Preventing and Treating Nausea and Vomiting After TACE
• Direct Peritoneal Resuscitation Plus Conventional Resuscitation
• Lipiodol as an Imaging Biomarker in Patients With Primary and Metastatic Liver Cancer
• Phase 1 TheraSphere + Everolimus With Neuroendocrine Tumors (NETs) + Liver Only or Liver Dominant Disease
• Selumetinib and Akt Inhibitor MK-2206 in Treating Patients With Refractory or Advanced Gallbladder or Bile Duct Cancer That Cannot Be Removed By Surgery
• Tremelimumab With Chemoembolization or Ablation for Liver Cancer
• HCV-RNA Kinetics During Sorafenib for Hepatocellular Carcinoma (HCC)
• Exploratory Study in Achievement of Improved Survival by Molecular Targeted Chemotherapy and Liver Resection for Not Optimally Resectable Colorectal Liver Metastases
• A Multicenter Phase I Study of MRX34, MicroRNA miR-RX34 Liposomal Injection
• ADH-1, Gemcitabine Hydrochloride and Cisplatin in Treating Patients With Locally Advanced or Metastatic Pancreatic or Biliary Tract Cancer That Cannot Be Removed by Surgery
• Parenteral Fish Oil in Major Laparoscopic Abdominal Surgery
• Phase II Trial of Tivozanib in Advanced Hepatocellular Cancer
• The Efficacy of Chlorhexidine Gluconate Pre - Disinfection Scrubbing in Preventing Surgical Site Infections for Hepatectomy Patients
• Sorafenib + mFOLFOX for Hepatocellular Carcinoma
• CPI-613 in Treating Patients With Advanced or Metastatic Bile Duct Cancer That Cannot Be Removed By Surgery
• Bevacizumab Therapy Untreated Unresectable Liver Metastases From Colorectal Cancer
• Systemic Therapy With or Without Upfront Transarterial Embolization for Inoperable Liver Metastasis of Neuroendocrine Tumors
• A Study of Vitamin C in the Treatment of Liver Cancer to Determine if it is Safe and Effective
• A Study With Tasquinimod Treating Patients With Hepatocellular, Ovarian, Renal Cell and Gastric Cancers
• CCR5-blockade in Metastatic Colorectal Cancer
• Sorafenib Tosylate With or Without Stereotactic Body Radiation Therapy in Treating Patients With Liver Cancer
• Expanded Access Study of Melphalan With Delcath CS-PHP System in Patients With Ocular/Cutaneous Melanoma Mets to Liver
• Methylprednisolone N Acetylcysteine in Hepatic Resections
• Chinese Herbal Formulation PHY906 and Sorafenib Tosylate in Treating Patients With Advanced Liver Cancer
• STA-9090 in Patients With Advanced Hepatocellular Cancer
• Study of Tranexamic Acid for Reducing Blood Requirement in Patients Undergoing Major Gastro-intestinal Surgery
• Efficacy of FOLFOX Versus FOLFOX Plus Aflibercept in K-ras Mutant Patients With Resectable Liver Metastases
• Genotype-guided Dosing of mFOLFIRINOX Chemotherapy in Patients With Previously Untreated Advanced Gastrointestinal Malignancies
• Preoperative CRT With or Without Induction Chemotherapy for Rectal Cancer With Liver Metastases
• Study of (1) Everolimus, (2) Estrogen Deprivation Therapy (EDT) With Leuprolide + Letrozole and (3) Everolimus + EDT in Patients With Unresectable Fibrolamellar Hepatocellular Carcinoma (FLL-HCC)
• Study of Peretinoin for Suppressing Recurrence of HCV-positive HCC
• A Study of CD45RA+ Depleted Haploidentical Stem Cell Transplantation in Children With Relapsed or Refractory Solid Tumors and Lymphomas
• Sorafenib Tosylate Following a Liver Transplant in Treating Patients With Liver Cancer
• Radiation Therapy With Sorafenib for TACE-Resistant Hepatocellular Carcinoma
• Phase II Trial Evaluating OS With Therasphere® + 2nd-Line FOLFOX in Pancreatic Liver Mets
• Cetuximab in Combination With Chemotherapy for the Treatment of Metastatic Colorectal Cancer
• Lenalidomide as Second-line Treatment for Advanced Hepatocellular Carcinoma
• Perioperative Treatment of Resectable Liver Metastases
• Hepatic Arterial Infusion in Treating Patients With Locally Advanced, Non-Metastatic Cholangiocarcinoma
• Intrahepatic Chemotherapy to Patients With Non-resectable Liver Metastases From Solid Tumor
• Efficacy of FOLFOX Alone, FOLFOX Plus Bevacizumab and FOLFOX Plus Panitumumab in Patients With Resectable Liver Metastases
• Profile of Soluble and Cellular Biomarkers and of Functional Imaging During Antiangiogenic Therapies in Cancer Patients
• Sorafenib Tosylate in Treating Younger Patients With Relapsed or Refractory Rhabdomyosarcoma, Wilms Tumor, Liver Cancer, or Thyroid Cancer
• Sorafenib Tosylate and Hypoxia-Activated Prodrug TH-302 in Treating Patients With Advanced Kidney Cancer or Liver Cancer That Cannot Be Removed By Surgery
• Phase 2 Study of Thermodox as Adjuvant Therapy With Thermal Ablation (RFA) in Treatment of Metastatic Colorectal Cancer(mCRC)
• Chemotherapies Associated With Targeted Therapies on the Resection Rate of Hepatic Metastases
• Prevention for the Development of Liver Tumorigenesis by the Oral Supplementation of Branched-chain Amino Acids
• Study of Gemcitabine With TheraSphere® (Yttrium-90)in Patients With Hepatic Tumors of Pancreatobiliary Origin
• MK2206 in Treating Patients With Advanced Refractory Biliary Cancer That Cannot Be Removed by Surgery
• Everolimus in de Novo Liver Transplantation: a Multicentre Randomized Study
• NHS-IL12 for Solid Tumors
• A Phase III PI-88 in the Adjuvant Treatment of Subjects With Hepatitis Virus Related HCC After Surgical Resection
• PET/CT in Diagnosing Patients With Liver Cancer Undergoing Surgical Resection
• Use of N-Acetylcysteine During Liver Procurement
• Intra-hepatic Chemotherapy in Patient With Non-resectable Liver Metastases From Breast Cancer
• Intra-hepatic Chemotherapy in Patients With Liver Metastases From Breast Cancer and Limited Extrahepatic Disease
• Panitumumab After Resection of Liver Metastases From Colorectal Cancer in KRAS Wild-type Patients
• TRC105 for Liver Cancer That Has Not Responded to Sorafenib
• A Clinical Research Study to Determine Whether PD 0332991 May Be Effective in Treating Patients With Liver Cancer
• Hepatic Arterial Chemotherapy With Raltitrexed and Oxaliplatin Versus Standard Chemotherapy in Unresectable Liver Metastases From Colorectal Cancer After Conventional Chemotherapy Failure
• Study With Dendritic Cell Immunotherapy in Resected Hepatic Metastasis of Colorectal Carcinoma
• A Phase II Trial of OSI-906 and Sorafenib in Advanced Hepatocellular Cancer
• Transarterial Chemoembolization Using Doxorubicin Beads With or Without Sorafenib Tosylate in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery
• Study of Cetuximab in Combination With mFOLFOX-6 (Oxaliplatin, Leucovorin, 5-FU) to Treat Colorectal Liver Metastatic Cancer Patients
• Combination Chemotherapy and Bevacizumab Before Surgery and Radiolabeled Monoclonal Antibody Therapy in Treating Liver Metastases in Patients With Metastatic Colorectal Cancer
• Gemcitabine Hydrochloride and Oxaliplatin or Observation in Treating Patients With Biliary Tract Cancer That Has Been Removed by Surgery
• New Adjuvant Chemotherapy of Non Resectable Liver Metastasis of Colorectal Cancer Without Bleeding, Obstruction
• Sorafenib and TRC105 in Hepatocellular Cancer
• Veliparib, Cisplatin, and Gemcitabine Hydrochloride in Treating Patients With Advanced Biliary, Pancreatic, Urothelial, or Non-Small Cell Lung Cancer
• Study of Pegylated Liposomal Doxorubicin and Temsirolimus in Patients With Advanced Hepatocellular Cancer
• Study of Bavituximab and Sorafenib In Patients With Advanced Liver Cancer
• A Study of Perioperative Chemotherapy Plus Panitumumab in Patients With Colorectal Cancer Liver Metastases
• Oxaliplatin and Capecitabine on Top of Sorafenib Versus Sorafenib Alone in Advanced Hepatocellular Carcinoma Patients
• MK2206 in Treating Patients With Advanced Liver Cancer That Did Not Respond to Previous Therapy
• Study of Hepatoma Treated by Perfusing Cinobufacin Through Hepatic Artery Combining Embolotherapy
• Perspective Evaluation of Hormones Involved in Serum Phosphate Homeostasis in Patients With Metastatic Renal Cells Carcinoma or Hepatocellular Carcinoma Treated With Sorafenib (SORHORM)
• Cediranib Maleate and Combination Chemotherapy in Treating Patients With Advanced Biliary Cancers
• Transcatheter Arterial Chemoembolization Therapy In Combination With Sorafenib
• Comparing Efficacy of Sorafenib Versus Sorafenib in Combination With Low-dose FP in Patients With Advanced HCC
• Clinical Evaluation of the New Hypoxia Imaging Agent HX4
• Predictive Value of 99mTc- Albumin Spheres Before 90Y- SIR Therapy
• Sorafenib Tosylate in Treating Patients With Liver Cancer That Can Be Removed by Surgery
• Erlotinib Plus Bevacizumab in Hepatocellular Carcinoma (HCC) as Second-line Therapy
• A Phase Ib Expansion Study Investigating the Safety, Efficacy, and Pharmacokinetics of Intravenous CUDC-101 in Subjects With Advanced Head and Neck, Gastric, Breast, Liver and Non-small Cell Lung Cancer Tumors
• Chemoembolization of the Liver With or Without Sunitinib Malate in Treating Patients With Liver Cancer
• Phase II SBRT & Chemo for Unresectable Cholangiocarcinoma Followed by Liver Transplantation
• Preventive Effect of Enoxaparin, Pentoxifylline and Ursodeoxycholic Acid to Radiation Induced Liver Toxicity
• A Pilot Study of EZN-2968, an Antisense Oligonucleotide Inhibitor of HIF-1alpha, in Adults With Advanced Solid Tumors With Liver Metastases
• Contrast-Enhanced CT and MRI in Diagnosing and Staging Liver Cancer Using UNOS Policy
• Temsirolimus in Treating Patients With Advanced Liver Cancer and Cirrhosis
• Sorafenib Tosylate With or Without Pravastatin in Treating Patients With Liver Cancer and Cirrhosis
• Study of [F 18]HX4 Positron Emission Tomography (PET) as a Tool to Detect Hypoxia in Tumors
• Sorafenib and Vorinostat in Treating Patients With Advanced Liver Cancer
• Liver MRI With Primovist/Eovist in Pediatric Subjects Who Are Suspected or Have Focal Liver Lesions.
• Isolated Liver Perfusion With Oxaliplatin
• Sorafenib Tosylate and Chemoembolization in Treating Patients With Unresectable Liver Cancer
• Compare FOFLOX4 in Preoperative and Postoperative and Postoperative in Resectable Liver Metastasis Colorectal Cancer (MCC)
• CS1008- in Combination With Sorafenib Compared to Sorafenib Alone in Subjects With Advanced Liver Cancer
• Study of Pazopanib and Ixabepilone in Patients With Solid Tumors
• Sorafenib Tosylate and Chemoembolization With Doxorubicin Hydrochloride and Mitomycin in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery
• Temsirolimus and Bevacizumab in Treating Patients With Advanced Endometrial, Ovarian, Liver, Carcinoid, or Islet Cell Cancer
• Transarterial Chemoembolization With Doxorubicin With or Without Everolimus in Treating Patients With Liver Cancer
• Efficacy and Tolerability of ABT-869 Versus Sorafenib in Advanced Hepatocellular Carcinoma (HCC)
• Cixutumumab and Sorafenib Tosylate in Treating Patients With Advanced Liver Cancer
• Stereotactic Radiation Therapy and Sorafenib in the Treatment of Hepatocellular Carcinoma
• Sorafenib Tosylate With or Without Everolimus in Treating Patients With Localized, Unresectable, or Metastatic Liver Cancer
• Evaluate Efficacy and Safety of XELOX in Potentially Resectable Liver Metastasis From Colorectal Cancer(CRC)
• Trial of Sorafenib in Hepatocellular Cancer (HCC) Transplant Patients
• Gemcitabine Hydrochloride, Oxaliplatin, and Erlotinib Hydrochloride in Treating Patients With Advanced Biliary Tract Cancer, Pancreatic Cancer, Duodenal Cancer, or Ampullary Cancer
• HAI Irinotecan + IV Bevacizumab, Bevacizumab & Oxaliplatin or Bevacizumab & Cetuximab in Advanced Cancers Metastatic to Liver
• Safety Study of Increasing Doses of Combretasatin A1 Diphosphate (OXi4503) as Monotherapy in Subjects With Hepatic Tumor Burden
• Acceptability of Less Harmful Alternatives to Cigarettes
• Chemoembolization Versus Radioembolization in Treating Patients With Liver Cancer That Cannot Be Treated With Radiofrequency Ablation Or Surgery
• Evaluation of Intra-operative Ultrasound Contrast Enhancement in the Evaluation of Liver Tumors
• Sorafenib Tosylate Before and After Hepatic Arterial Chemoembolization With Doxorubicin Hydrochloride and Mitomycin C in Treating Patients With Localized Liver Cancer That Cannot Be Removed by Surgery
• Sorafenib With or Without Gemcitabine and Oxaliplatin in Treating Patients With Locally Advanced, Unresectable, or Metastatic Liver Cancer
• Palonosetron Hydrochloride in Preventing Nausea and Vomiting Caused by Radiation Therapy in Patients With Primary Abdominal Cancer
• Sorafenib-RT Treatment for Liver Metastasis (SLIM)
• Bevacizumab and Erlotinib or Sorafenib as First-Line Therapy in Treating Patients With Advanced Liver Cancer
• Cisplatin or Carboplatin and Sorafenib in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery
• Impact of Pre-operative Bevacizumab on Complications After Resection of Colorectal Liver Metastases
• Panobinostat and Sorafenib in Treating Patients With Liver Cancer That is Metastatic and/or Cannot Be Removed by Surgery
• Iodine I 131 Ethiodized Oil in Preventing Recurrent Cancer in Patients Who Have Undergone Treatment for Liver Cancer
• Bevacizumab and Sorafenib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Liver Cancer
• Study of Adecatumumab Relative to FOLFOX After R0 Resection of Colorectal Liver Metastases
• Safety of ON 01910.Na and Irinotecan or ON 01910.Na and Oxaliplatin in Patients With Hepatoma
• Yttrium Y 90 Glass Microspheres and Capecitabine in Treating Patients With Liver Cholangiocarcinoma or Liver Metastases
• Optimal Control of Liver Metastases From Colorectal Cancer With Cetuximab and Hepatic Artery Infusion of Chemotherapy
• Prevention of Liver Damage During Liver Surgery
• Sorafenib Tosylate in Treating Patients With Liver Cancer Who Have Undergone a Liver Transplant
• Cetuximab and/or Dasatinib in Patients With Colorectal Cancer and Liver Metastases That Can Be Removed by Surgery
• SonoVue®-Enhanced Ultrasound (US) Versus Unenhanced US for Focal Liver Lesion Characterization
• Comparison of Brivanib and Best Supportive Care to Placebo for Treatment of Liver Cancer for Those Subjects Who Have Failed Sorafenib Treatment
• Efficacy and Significance of Antiviral Therapy for Unresectable Hepatitis B Virus-related Primary Liver Cancer
• Sorafenib Therapy Prior to Radiofrequency Ablation for Intermediate Sized Hepatocellular Cancer
• FOLFIRI and Sunitinib in Metastatic Colorectal Cancer
• Varenicline or Nicotine Patch and Nicotine Gum in Helping Smokers in a Methadone Treatment Program Stop Smoking
• SonoVue®-Enhanced Ultrasound Versus Unenhanced US for Focal Liver Lesion Characterization
• Dasatinib, Ifosfamide, Carboplatin, and Etoposide in Treating Young Patients With Metastatic or Recurrent Malignant Solid Tumors
• Sunitinib Malate and Capecitabine in Treating Patients With Unresectable or Metastatic Liver Cancer
• Antiangiogenic Treatment of Hepatocellular Cancer With Bevacizumab and RAD001
• Sorafenib in Treating Patients With Locally Advanced or Metastatic Liver Cancer and Cirrhosis
• Neoadjuvant FOLFOX6 + Cetuximab in Patients With Colorectal Cancer and Unresectable Liver Metastasis
• FOLFOX6 Plus Sir-Spheres Microspheres Plus Avastin in Patients With Nonresectable Liver Metastases From Colorectal Carcinoma
• Hepatic Arterial Infusion (HAI) of Abraxane
• Low-Dose Thalidomide as Adjuvant Therapy After Radiofrequency Ablation for Hepatocellular Carcinoma
• FOLFOX Plus SIR-SPHERES MICROSPHERES Versus FOLFOX Alone in Patients With Liver Mets From Primary Colorectal Cancer
• Cixutumumab and Doxorubicin Hydrochloride in Treating Patients With Unresectable, Locally Advanced, or Metastatic Soft Tissue Sarcoma
• Lenalidomide for Advanced Hepatocellular Cancer:A Phase II Trial
• Sodium Thiosulfate in Preventing Hearing Loss in Young Patients Receiving Cisplatin for Newly Diagnosed Germ Cell Tumor, Hepatoblastoma, Medulloblastoma, Neuroblastoma, Osteosarcoma, or Other Malignancy
• Treatment of Unresectable Hepatocellular Cancer With Opioid Growth Factor
• Immunization With AFP + GM CSF Plasmid Prime and AFP Adenoviral Vector Boost in Patients With Hepatocellular Carcinoma
• Health Education Counseling With or Without Bupropion in Helping African Americans Stop Smoking
• Neo-adjuvant Therapy and the Effect on Synchronous Metastatic Growth
• Gemcitabine With/Out Capecitabine in Locally Advanced, Unresectable, or Metastatic Biliary Cancer
• Irinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Gastrointestinal Cancer
• Cisplatin With or Without Sodium Thiosulfate in Treating Young Patients With Stage I, II, or III Childhood Liver Cancer
• Hepatic Arterial Infusion of Floxuridine, Gemcitabine Hydrochloride, and Radiolabeled Monoclonal Antibody Therapy in Treating Liver Metastases in Patients With Metastatic Colorectal Cancer Previously Treated With Surgery
• Phase 3 Study of Surgery Combined With Neoadjuvant Chemotherapy(XELOX) in Colorectal Cancer With Resectable Liver Metastasis
• MT2004-30: Tomotherapy for Solid Tumors
• Dasatinib in Treating Patients With Solid Tumors or Lymphomas That Are Metastatic or Cannot Be Removed By Surgery
• A Study of Tarceva (Erlotinib) and Avastin (Bevacizumab) in Patients With Advanced or Metastatic Liver Cancer.
• Selumetinib in Treating Patients With Locally Advanced or Metastatic Liver Cancer
• Study of Capecitabine in Combination With SIR-Spheres in Patients With Advanced Cancer
• A Phase II Study of Continuous Hepatic Arterial Infusion With Floxuridine (FUDR) and Dexamethasone (DEX) in Patients With Unresectable Primary Hepatic Malignancy
• Contrast Sonography for Evaluation of Liver Tumors Prior to Radiofrequency Ablation
• A Study of Avastin (Bevacizumab) and Transarterial Chemoembolisation (TACE) Treatment in Patients With Liver Cancer
• Atropine for Prevention of Dysrhythmias Caused by Percutaneous Ethanol Instillation for Hepatoma Therapy
• Phase III Study of PI-88 in Post-resection Hepatocellular Carcinoma
• Safety Study of Oxaliplatin and 5-fluorouracil Followed by FUDR for Unresectable Colorectal Liver Metastases
• Nucleoid as an Adjuvant Therapy After Radiofrequency Ablation for Hepatocellular Carcinoma
• Cyclophosphamide, Radiation Therapy, and Poly ICLC in Treating Patients With Unresectable, Recurrent, Primary, or Metastatic Liver Cancer
• A Trial Evaluating the Pharmacokinetics and Mode of Action of EndoTAG®-1 in Tumor Patients With Hepatic Metastases
• Assessment of Liver Cancer Response to TACE Using MultiHance-Enhanced MRI.
• Vorinostat, Irinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Upper Gastrointestinal Cancer
• Bupropion in Helping Adults Stop Smoking
• Sunitinib and Chemoembolization in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery
• Preoperative Hepatic Arterial Infusion Chemotherapy
• Sunitinib in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery
• Liver Cancer Prevention Trial in Patients With Chronic Hep C Infection
• Study Comparing Radio Frequency Ablation Plus Chemotherapy and Chemotherapy Alone in Patients With Secondary Liver Metastases
• Folfox-B Study for Patients With Colorectal Liver Metastases
• Hepatic Arterial Infusion of Oxaliplatin, Fluorouracil, Leucovorin, and Avastin
• Phase I Study With AZD2171 in Patients With Advanced Solid Malignant Tumors and Liver Metastases
• Sunitinib Malate (SUO11248) In Subjects W/ Metastatic And/Or Surgically Unresectable Hepatocellular Cancers (HCC)
• Capecitabine, Epirubicin, and Carboplatin in Treating Patients With Progressive, Unresectable, or Metastatic Cancer
• Oxaliplatin, Capecitabine, and Cetuximab in Treating Patients With Advanced Liver Cancer
• Combination Chemotherapy and Interferon Alfa-2b in Treating Patients With Nonmetastatic Liver Cancer That Cannot Be Removed by Surgery
• Chemotherapy or Not, Following Complete Treatment of Hepatic Cancer in Cirrhotic Patients
• Sirolimus and Bevacizumab in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery
• Dasatinib in Treating Patients With Advanced Liver Cancer That Cannot Be Removed by Surgery
• A Study of ThermoDox™ in Combination With Radiofrequency Ablation (RFA) in Primary and Metastatic Tumors of the Liver
• Phase 3 Trial of Litx™ Plus Chemotherapy vs. Chemotherapy Only Treating Colorectal Cancer Patients With Recurrent Liver Metastases
• AZD2171 in Treating Patients With Locally Advanced Unresectable or Metastatic Liver Cancer
• Proton Therapy and Bevacizumab for Primary Liver Tumors
• Taxoprexin® Treatment for Advanced Primary Cancers of the Liver
• Floxuridine and Dexamethasone as a Hepatic Arterial Infusion and Bevacizumab in Treating Patients With Primary Liver Cancer That Cannot be Removed by Surgery
• Erlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal Cancer
• Adjuvant Xeloda Plus Eloxatin +/- Avastin After Radical Resection of Liver Metastasis of Colorectal Cancer
• Escitalopram in Treating Depression in Patients With Advanced Lung or Gastrointestinal Cancer
• Study of Irofulven in Combination With Oxaliplatin in Patients With Advanced Solid Tumors
• A Phase I Study of Pazopanib in Adult Patients With Liver Cancer
• Counseling and Nicotine Replacement Therapy in Helping Adult Smokers Quit Smoking
• Bevacizumab and Erlotinib in Treating Patients With Advanced Liver Cancer
• Capecitabine or Observation After Surgery in Treating Patients With Biliary Tract Cancer
• SU011248 in Advanced Hepatocellular Carcinoma
• A Phase 3 Study of Talaporfin Sodium and Interstitial Light Emitting Diodes Treating Hepatocellular Carcinoma (HCC)
• Combination Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Rhabdomyosarcoma
• Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue Sarcoma
• Bevacizumab and Chemoembolization in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery
• Study of Safety and Tolerability of Intravenous CRS-100 in Adults With Carcinoma and Liver Metastases
• Belinostat in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery
• Fluorouracil, Cisplatin, and Radiation Therapy or Gemcitabine and Oxaliplatin in Treating Patients With Nonmetastatic Biliary Tract Cancer That Cannot Be Removed By Surgery
• Talabostat Combined With Temozolomide or Carboplatin in Treating Young Patients With Relapsed or Refractory Brain Tumors or Other Solid Tumors
• Celecoxib and Erlotinib in Treating Patients With Liver Cancer
• Irinotecan in Treating Young Patients With Refractory or Recurrent Hepatoblastoma
• Adjuvant Therapy of Gefitinib (Iressa, ZD1839) in Patients With Resectable Hepatocellular Carcinoma
• Combination Chemotherapy and Thalidomide in Treating Younger Patients Undergoing Surgery For Newly Diagnosed Liver Cancer
• Octreotide in Treating Patients With Locally Advanced or Metastatic Liver Cancer
• Gemcitabine and Oxaliplatin for Hepatocellular Carcinoma With Platelet Counts Greater Than 100,000 Per Microliter
• An International Phase 2 Study Of SU011248 In Patients With Inoperable Liver Cancer
• Hepatic Artery Infusion With Oxaliplatin
• Efficacy and Safety Study of Bevacizumab and Erlotinib to Treat Primary Liver Cancer That Cannot be Removed By Surgery
• Cediranib Maleate in Treating Patients With Locally Advanced or Metastatic Liver Cancer
• Surgery With or Without Hepatic Arterial Chemotherapy in Treating Patients With Liver Cancer
• Dose Escalation Study Combining Oral Capecitabine (Xeloda) and Radiotherapy for Patients With Unresectable Liver or Cholangiocarcinoma
• Intensified Chemotherapy in CRC After Resection of Liver Metastases
• Hepatic Arterial Infusion With Floxuridine and Dexamethasone Combination With Chemotherapy With/Without Bevacizumab for Hepatic Metastases From Colorectal Cancer
• A Study of Pemetrexed in the Treatment of Patients With Advanced Metastatic Cancer of the Liver
• Recombinant Human Thrombopoietin in Children Receiving Ifosfamide, Carboplatin, and Etoposide Chemotherapy
• A Phase II Study of Intra-arterial Chemotherapy With Cisplatin and Mitomycin-C in Patients With Hepatocellular Carcinoma
• Study of 5-FU + Leucovorin + CPT-11 in Patients With Resectable Liver Metastases From Colorectal Adenocarcinoma
• Oxaliplatin and Capecitabine Versus Follow-up After Resection of Colorectal Liver Metastases
• Cetuximab in Neoadjuvant Treatment of Non-Resectable Colorectal Liver Metastases (CELIM)
• Effect of a Perioperative Oral Nutritional Supplementation on Patients Undergoing Hepatic Surgery for Liver Cancer
• Safety & Efficacy of NV1020 in Colorectal Cancer Metastatic to the Liver
• Comparing Irinotecan and 5 FU/FA To 5-FU/FA After Resection Of Liver Metastases For Colorectal Cancer
• Arsenic Trioxide in Treating Patients With Metastatic Liver Cancer That Cannot Be Removed by Surgery
• Tumor Ablation With Talaporfin Sodium and Interstitial Light Emitting Diodes Treating Hepatocellular Carcinoma (HCC)
• Hepatic Arterial Chemoembolization With Cisplatin or Internal Radiation Therapy in Treating Patients With Advanced Liver Cancer That Cannot Be Removed By Surgery
• Lapatinib Ditosylate in Treating Patients With Unresectable Liver or Biliary Tract Cancer
• Neoadjuvant Colorectal Cancer With Unresectable Liver Metastases
• Oxaliplatin and Irinotecan in Treating Young Patients With Refractory Solid Tumors or Lymphomas
• Lapatinib in Treating Patients With Locally Advanced or Metastatic Biliary Tract or Liver Cancer That Cannot Be Removed By Surgery
• Hepatic Arterial Infusion of Melphalan With Hepatic Perfusion in Treating Patients With Unresectable Liver Cancer
• SB-715992 in Treating Patients With Locally Advanced, Recurrent, or Metastatic Liver Cancer
• Study of NS-9 in Patients With Liver Metastases
• Heat Activated Liposomal Doxorubicin and Radiofrequency Ablation in Treating Patients With Primary or Metastatic Liver Tumors
• Oxaliplatin in Treating Young Patients With Recurrent Solid Tumors That Have Not Responded to Previous Treatment
• Irinotecan and Flavopiridol in Treating Patients With Advanced Liver Cancer
• EF5 and Motexafin Lutetium in Detecting Tumor Cells in Patients With Abdominal or Non-Small Cell Lung Cancer
• Bortezomib in Treating Patients With Unresectable Locally Advanced or Metastatic Adenocarcinoma of the Bile Duct or Gallbladder
• Study of the Litx™ System Combined With Chemotherapy in Patients With Colorectal Liver Metastases
• Doxorubicin and Bortezomib in Treating Patients With Liver Cancer
• Vaccine Therapy and Radiation to Liver Metastasis in Patients With CEA-Positive Solid Tumors
• Doxorubicin By Infusion or Chemoembolization in Treating Patients With Advanced Unresectable Hepatocellular Carcinoma (Liver Cancer)
• Bortezomib in Treating Patients With Hepatocellular Carcinoma (Liver Cancer)
• Intensive Neoadjuvant Chemotherapy in Treating Young Patients Undergoing Surgical Resection for High-Risk Hepatoblastoma
• TAC-101 in Treating Patients With Advanced Hepatocellular Carcinoma (Liver Cancer)
• Study of Botanical PHY906 Plus Capecitabine for Advanced Unresectable Hepatocellular Carcinoma
• Adjuvant Palliative Capecitabine and Gemcitabine in Treating Patients With Locally Advanced or Metastatic Biliary Tract Cancer
• Gefitinib in Treating Patients With Advanced Unresectable Hepatocellular Carcinoma (Liver Cancer)
• Neoadjuvant and Adjuvant Capecitabine and Oxaliplatin in Treating Patients With Resectable Liver Metastases Secondary to Colorectal Cancer
• Photodynamic Therapy With Talaporfin Sodium (LS11) in Treating Patients With Refractory Colorectal Liver Metastases
• Gemcitabine Plus Pemetrexed Disodium in Treating Patients With Unresectable or Metastatic Biliary Tract or Gallbladder Cancer
• Epirubicin and Thalidomide in Treating Patients With Liver Cancer
• Epirubicin and Celecoxib in Treating Patients With Hepatocellular Carcinoma
• T900607 in Treating Patients With Unresectable Liver Cancer
• Oxaliplatin in Treating Patients With Liver Cancer
• Seocalcitol Versus Placebo in the Adjuvant Treatment of Hepatocellular Carcinoma
• Seocalcitol Versus Placebo in Advanced Hepatocellular Carcinoma
• Erlotinib in Treating Patients With Unresectable Liver Cancer and Liver Dysfunction
• Erlotinib in Treating Patients With Liver Cancer That Cannot be Surgically Removed
• Oblimersen and Doxorubicin in Treating Patients With Advanced Hepatocellular Carcinoma (Liver Cancer)
• Chemotherapy and Bevacizumab With or Without Radiofrequency Ablation in Treating Unresectable Liver Metastases in Patients With Colorectal Cancer
• Magnetic-Targeted Doxorubicin in Treating Patients With Cancer Metastatic to the Liver
• Megestrol in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery
• ABT-751 in Treating Young Patients With Refractory Solid Tumors
• Erlotinib in Treating Patients With Unresectable Liver, Bile Duct, or Gallbladder Cancer
• 7-Hydroxystaurosporine and Irinotecan Hydrochloride in Treating Patients With Metastatic or Unresectable Solid Tumors or Triple Negative Breast Cancer (Currently Accruing Only Triple-negative Breast Cancer Patients Since 6/8/2007)
• Radiation Therapy and Fluorouracil Before Surgery in Treating Patients With Primary or Recurrent Bile Duct Cancer
• Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney Dysfunction
• Ixabepilone in Treating Young Patients With Solid Tumors or Leukemia That Haven't Responded to Therapy
• Hepatic Arterial Infusion With Melphalan in Treating Patients With Unresectable Liver Cancer
• Arsenic Trioxide in Treating Patients With Advanced Neuroblastoma or Other Childhood Solid Tumors
• BMS-247550 in Treating Patients With Liver or Gallbladder Cancer
• Epirubicin, Carboplatin, and Capecitabine in Treating Patients With Unresectable Locally Advanced, Metastatic, or Recurrent Solid Tumor
• SCH 66336 With or Without Gemcitabine Followed by Surgery Compared With Surgery Alone in Treating Patients With Primary Liver Cancer
• Temozolomide and O6-benzylguanine in Treating Children With Solid Tumors
• Isolated Hepatic Perfusion With Melphalan in Treating Patients With Primary Unresectable Liver Cancer or Liver Metastases
• Liposomal Doxorubicin in Treating Children With Refractory Solid Tumors
• Combination Chemotherapy in Treating Patients With Recurrent, Refractory, or Metastatic Solid Tumors or Lymphomas
• Combination Chemotherapy Plus Interferon Alfa Followed by Filgrastim in Treating Patients With Gastrointestinal Tract Cancer
• Vaccine Therapy Plus Biological Therapy in Treating Adults With Metastatic Solid Tumors
• Nolatrexed Dihydrochloride Compared With Doxorubicin in Treating Patients With Recurrent or Unresectable Liver Cancer
• Flavopiridol in Treating Children With Relapsed or Refractory Solid Tumors or Lymphomas
• Combination Chemotherapy in Treating Patients With Unresectable or Metastatic Biliary Tract or Gallbladder Cancer
• Peripheral Stem Cell Transplantation Plus Chemotherapy in Treating Patients With Malignant Solid Tumors
• Chronic Thalidomide Administration in Patients Undergoing Chemoembolization for Unresectable Hepatocellular Cancer
• Thalidomide and Chemoembolization With Doxorubicin in Treating Patients With Liver Cancer That Cannot be Removed by Surgery
• Gemcitabine Plus Docetaxel in Treating Patients With Unresectable or Metastatic Liver Cancer
• Thalidomide Plus Interferon Alfa in Treating Patients With Progressive Liver Cancer That Cannot be Surgically Removed
• Rebeccamycin Analogue in Treating Patients With Advanced Liver and/or Biliary Cancer
• DX-8951f in Treating Patients With Biliary Cancer
• Doxorubicin and Interleukin-2 in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery
• DX-8951f in Treating Patients With Liver Cancer
• Combination Chemotherapy With or Without Amifostine in Treating Young Patients With Liver Cancer
• Combination Chemotherapy in Treating Patients With Previously Untreated Rhabdomyosarcoma
• Amifostine to Protect From Side Effects of PSCT in Treating Patients With Solid Tumors
• Photodynamic Therapy in Treating Patients With Cancer of the Bile Duct, Gallbladder, or Pancreas
• Chemotherapy in Treating Children With Liver Cancer
• Chemoembolization in Treating Patients With Primary Liver Cancer or Metastases to the Liver
• Chemotherapy in Treating Patients With Unresectable Primary or Metastatic Kidney Cancer
• Dolastatin 10 in Treating Patients With Metastatic Or Recurrent Liver, Bile Duct, or Gallbladder Cancer
• Antineoplaston Therapy in Treating Patients With Primary Liver Cancer
• Oxaliplatin Plus Irinotecan in Treating Patients With Metastatic Gastrointestinal Cancer
• Tamoxifen in Treating Patients With Primary Liver Cancer
• Liposomal Doxorubicin in Treating Patients With Liver or Bile Duct Cancer
• Chemotherapy in Treating Patients With Liver Cancer
• Combination Chemotherapy and Tamoxifen in Treating Patients With Solid Tumors
• Combination Chemotherapy Followed by Bone Marrow Transplantation in Treating Patients With Rare Cancer
• A Phase I Study of Isolated Hepatic Portal and Arterial Perfusion (IHP) With Escalating Dose Melphalan for Primary or Metastatic Unresectable Cancers of the Liver
• A Phase I Study of Isolated Hepatic Perfusion With Escalating Dose Melphalan Followed by Postoperative Hepatic Arterial Floxuridine and Leucovorin for Metastatic Unresectable Colorectal Cancers of the Liver